Phase 4 Crohn's Disease and Colitis Trial, Recruiting NCT06520397 Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University Condition: Crohn's Disease and Colitis
Back to Crohns Disease And Colitis

Phase 4 Crohn's Disease and Colitis Trial, Recruiting

NCT06520397
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 70 years old.
  • You have been diagnosed with active Crohn's disease, confirmed by a specific type of camera examination of the gut (endoscopy) and blood or stool tests, or imaging scans.
  • Your Crohn's disease symptoms score above a certain level on a standard measurement scale used by doctors (confirm with trial site for exact score details).
  • You previously tried a type of medication called a TNF inhibitor, but it did not work well enough or stopped working over time.
  • You have been taking a medication called ustekinumab at the standard dose for at least 16 to 24 weeks, but your Crohn's disease is still active.
  • You are willing and able to sign a consent form and follow the study's requirements throughout the trial.
  • A doctor has reviewed your overall health — including blood tests, a physical exam, a chest X-ray, and a heart tracing (ECG) — and considers you generally healthy enough to participate.

Who may not be able to join:

  • You have a known allergy to upadacitinib (UPA) or ustekinumab (UST), or to any of their ingredients.
  • You have untreated or unresolved pre-cancerous changes (high-grade dysplasia) or cancer of the colon.
  • You have an active infection right now, such as pneumonia, a kidney infection, or shingles, or you have a long-term (chronic) infection that the doctor feels makes participation unsafe.
  • You currently need surgery for your Crohn's disease, or it is expected that you will need surgery during the study.
  • You have been found to have blood clots, based on an ultrasound scan of your legs or a blood test (D-dimer).
  • You have a history of lymphoma or other diseases affecting the lymph system, or you currently have swollen lymph nodes or an enlarged spleen that may suggest such a condition.
  • You have a condition that weakens your immune system, such as a condition you were born with, HIV infection, or you have received an organ transplant.
  • You are pregnant, or a pregnancy test at the start of the study comes back positive.
  • You are currently breastfeeding or planning to become pregnant during the study.
  • You have used illegal drugs or misused alcohol within the past year before joining the study.
  • The doctor running the trial decides, for any reason, that the study is not suitable for you.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 86-020-38254101

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Registry
ClinicalTrials.gov
Start date
15 July 2024
Est. completion
31 December 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The primary endpoint of the study is the endoscopic remission rate at week 16.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov